{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:39:34Z","timestamp":1784770774148,"version":"3.55.0"},"reference-count":69,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,4,29]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not diagnosed and treated accordingly. CRS generally occurs with therapies that lead to highly activated T cells, like chimeric antigen receptor T cells or in the case of bispecific T-cell engaging antibodies. This, in turn, leads to a proinflammatory state with subsequent organ damage. To better manage CRS there is a need for specific therapies or to repurpose strategies that are already known to be useful in similar situations. Current management strategies for CRS are represented by anticytokine directed therapies and corticosteroids. Based on its pathophysiology and the resemblance of CRS to sepsis and septic shock, as well as based on the principles of initiation of continuous renal replacement therapy (CRRT) in sepsis, we propose the rationale of using CRRT therapy as an adjunct treatment in CRS where all the other approaches have failed in controlling the clinically significant manifestations.<\/jats:p>","DOI":"10.1136\/jitc-2020-000742","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T17:47:30Z","timestamp":1590860850000},"page":"e000742","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?"],"prefix":"10.1136","volume":"8","author":[{"given":"Catalin","family":"Constantinescu","sequence":"first","affiliation":[{"name":"Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"},{"name":"Department of Anesthesia - Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Pasca","sequence":"additional","affiliation":[{"name":"Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"},{"name":"Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberiu","family":"Tat","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patric","family":"Teodorescu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"},{"name":"Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Vlad","sequence":"additional","affiliation":[{"name":"Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Iluta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"},{"name":"Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Dima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Tomescu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia - Intensive Care, Carol Davila University of Medicine and Pharmacy, Bucuresti, Romania"},{"name":"Department of Anesthesia - Intensive Care, Fundeni Clinical Institute, Bucuresti, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecaterina","family":"Scarlatescu","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Tanase","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur Eysteinn","family":"Sigurjonsson","sequence":"additional","affiliation":[{"name":"University of Reykjavik, Reykjavik, Iceland"},{"name":"Bloodbank, Landspitali National University Hospital of Iceland, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Colita","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, Clinical Institute Fundeni, Bucuresti, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg, Wurzburg, Bayern, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Tomuleasa","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"key":"2025100312052019000_8.1.e000742.1","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/cam4.1461","article-title":"Incidence and survival of hematological cancers among adults ages \u226575 years","volume":"7","author":"Krok-Schoen","year":"2018","journal-title":"Cancer Med"},{"key":"2025100312052019000_8.1.e000742.2","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in car T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Molecular Therapy - Oncolytics"},{"key":"2025100312052019000_8.1.e000742.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-485623"},{"key":"2025100312052019000_8.1.e000742.4","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S202015"},{"key":"2025100312052019000_8.1.e000742.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.756"},{"key":"2025100312052019000_8.1.e000742.6","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9"},{"key":"2025100312052019000_8.1.e000742.7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002053"},{"key":"2025100312052019000_8.1.e000742.8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","article-title":"Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls","volume":"22","author":"Ankawi","year":"2018","journal-title":"Critical Care"},{"key":"2025100312052019000_8.1.e000742.9","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S150524"},{"key":"2025100312052019000_8.1.e000742.10","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2016-0020"},{"key":"2025100312052019000_8.1.e000742.11","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230924"},{"key":"2025100312052019000_8.1.e000742.12","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4989"},{"key":"2025100312052019000_8.1.e000742.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4"},{"key":"2025100312052019000_8.1.e000742.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215134"},{"key":"2025100312052019000_8.1.e000742.15","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3153"},{"key":"2025100312052019000_8.1.e000742.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729"},{"key":"2025100312052019000_8.1.e000742.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"2025100312052019000_8.1.e000742.18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008226"},{"key":"2025100312052019000_8.1.e000742.19","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1609783"},{"key":"2025100312052019000_8.1.e000742.20","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/cncr.30031","article-title":"Blinatumomab treatment of older adults with relapsed\/refractory B-precursor acute lymphoblastic leukemia: results from 2 phase 2 studies","volume":"122","author":"Kantarjian","year":"2016","journal-title":"Cancer"},{"key":"2025100312052019000_8.1.e000742.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71170-2"},{"key":"2025100312052019000_8.1.e000742.22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"The Cancer Journal"},{"key":"2025100312052019000_8.1.e000742.23","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1629904"},{"key":"2025100312052019000_8.1.e000742.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2016.03.005"},{"key":"2025100312052019000_8.1.e000742.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214367"},{"key":"2025100312052019000_8.1.e000742.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-703751"},{"key":"2025100312052019000_8.1.e000742.27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40265-018-0929-z","article-title":"Sarilumab: a review in moderate to severe rheumatoid arthritis","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"key":"2025100312052019000_8.1.e000742.28","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.1.2.141.62908"},{"key":"2025100312052019000_8.1.e000742.29","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/cc12587","article-title":"Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study","volume":"17","author":"Rimmel\u00e9","year":"2013","journal-title":"Critical Care"},{"key":"2025100312052019000_8.1.e000742.30","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.18632\/oncotarget.13254","article-title":"Effects of continuous renal replacement therapy on serum cytokines, neutrophil gelatinase-associated lipocalin, and prognosis in patients with severe acute kidney injury after cardiac surgery","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"2025100312052019000_8.1.e000742.31","first-page":"476","article-title":"Optimizing continuous renal replacement therapy in the ICU","volume":"24","author":"Joannes-Boyau","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"2025100312052019000_8.1.e000742.32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2478\/jtim-2018-0016","article-title":"What a clinician should know about a renal replacement membrane?","volume":"6","author":"Honore","year":"2018","journal-title":"J Transl Intern Med"},{"key":"2025100312052019000_8.1.e000742.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.09.004"},{"key":"2025100312052019000_8.1.e000742.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2008.00545.x"},{"key":"2025100312052019000_8.1.e000742.35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0272-6386(86)80025-7","article-title":"Regional anticoagulation: hemodialysis with hypertonic trisodium citrate","volume":"8","author":"von Brecht","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"2025100312052019000_8.1.e000742.36","doi-asserted-by":"publisher","DOI":"10.1007\/BF01694706"},{"key":"2025100312052019000_8.1.e000742.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902413"},{"key":"2025100312052019000_8.1.e000742.38","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318256f0c0"},{"key":"2025100312052019000_8.1.e000742.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-2967-z"},{"key":"2025100312052019000_8.1.e000742.40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41100-016-0051-1","article-title":"Cytokine-adsorbing hemofilter: old but new modality for septic acute kidney injury","volume":"2","author":"Hattori","year":"2016","journal-title":"Ren Replace Ther"},{"key":"2025100312052019000_8.1.e000742.41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/CJI.0000000000000243","article-title":"Hemofiltration successfully eliminates severe cytokine release syndrome following CD19 CAR-T-Cell therapy","volume":"41","author":"Liu","year":"2018","journal-title":"J Immunother"},{"key":"2025100312052019000_8.1.e000742.42","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199910000-00003"},{"key":"2025100312052019000_8.1.e000742.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1379"},{"key":"2025100312052019000_8.1.e000742.44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/039139880602900901","article-title":"Sorbents: from bench to bedside can we combine membrane separation processes and adsorbent based solute removal?","volume":"29","author":"Ronco","year":"2006","journal-title":"Int J Artif Organs"},{"key":"2025100312052019000_8.1.e000742.45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000492379","article-title":"Clinical utility of extracorporeal cytokine Hemoadsorption therapy: a literature review","volume":"46","author":"Bonavia","year":"2018","journal-title":"Blood Purif"},{"key":"2025100312052019000_8.1.e000742.46","unstructured":"The Adsorber [Internet] . CytoSorbents Europe GmbH. Available: https:\/\/cytosorb-therapy.com\/en\/the-adsorber\/ [Accessed 14 Feb 2020]."},{"key":"2025100312052019000_8.1.e000742.47","unstructured":"The Therapy [Internet] . CytoSorbents Europe GmbH. Available: https:\/\/cytosorb-therapy.com\/en\/the-therapy\/ [Accessed 14 Feb 2020]."},{"key":"2025100312052019000_8.1.e000742.48","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000291646.34815.BB"},{"key":"2025100312052019000_8.1.e000742.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187015","article-title":"The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial","volume":"12","author":"Sch\u00e4dler","year":"2017","journal-title":"PLoS One"},{"key":"2025100312052019000_8.1.e000742.50","doi-asserted-by":"crossref","first-page":"P62","DOI":"10.1186\/cc12000","article-title":"A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients","volume":"17","author":"Sch\u00e4dler","year":"2013","journal-title":"Crit Care"},{"key":"2025100312052019000_8.1.e000742.51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10047-017-0991-4","article-title":"Efficacy of hemofiltration with PEPA membrane for IL-6 removal in a rat sepsis model","volume":"20","author":"Maeda","year":"2017","journal-title":"J Artif Organs"},{"key":"2025100312052019000_8.1.e000742.52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"ICMx"},{"key":"2025100312052019000_8.1.e000742.53","first-page":"681","article-title":"Coupled plasma filtration adsorption (CPFA) plus continuous Veno-Venous haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis","volume":"12","author":"Hassan","year":"2013","journal-title":"Excli J"},{"key":"2025100312052019000_8.1.e000742.54","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.11904"},{"key":"2025100312052019000_8.1.e000742.55","doi-asserted-by":"crossref","unstructured":"Gutgarts V , Jain T , Zheng J , et al . Acute kidney injury after CAR-T cell therapy: low incidence and rapid recovery. Biol blood marrow transplant. J Am Soc Blood Marrow Transplant 2020.","DOI":"10.1016\/j.bbmt.2020.02.012"},{"key":"2025100312052019000_8.1.e000742.56","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2019.10.011","article-title":"Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma","author":"Gupta","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2025100312052019000_8.1.e000742.57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.56.s72.1.x"},{"key":"2025100312052019000_8.1.e000742.58","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000286343","article-title":"Continuous renal replacement therapy does not have a clear role in the treatment of poisoning","volume":"115","author":"Kim","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"2025100312052019000_8.1.e000742.59","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/cncr.30180","article-title":"Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation","volume":"122","author":"Gaballa","year":"2016","journal-title":"Cancer"},{"key":"2025100312052019000_8.1.e000742.60","first-page":"194","article-title":"First successful haploidentical stem cell transplantation in Romania","volume":"54","author":"T\u0103nase","year":"2016","journal-title":"Rom J Intern Med"},{"key":"2025100312052019000_8.1.e000742.61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000443469","article-title":"Haploidentical donors: can faster transplantation be Life-Saving for patients with advanced disease?","volume":"135","author":"Tanase","year":"2016","journal-title":"Acta Haematol"},{"key":"2025100312052019000_8.1.e000742.62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbmt.2015.10.015","article-title":"Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning","volume":"22","author":"Brammer","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025100312052019000_8.1.e000742.63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00892","article-title":"LEAM vs. beam vs. CLV conditioning regimen for autologous stem cell transplantation in malignant lymphomas. retrospective comparison of toxicity and efficacy on 222 patients in the first 100 days after transplant, on behalf of the Romanian Society for bone marrow transplantation","volume":"9","author":"Colita","year":"2019","journal-title":"Front Oncol"},{"key":"2025100312052019000_8.1.e000742.64","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/jcm8081175","article-title":"Approach to the adult acute lymphoblastic leukemia patient","volume":"8","author":"Sas","year":"2019","journal-title":"JCM"},{"key":"2025100312052019000_8.1.e000742.65","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/jcm8060884","article-title":"Clinical approach to the patient in critical state following immunotherapy and\/or stem cell transplantation: guideline for the on-call physician","volume":"8","author":"Constantinescu","year":"2019","journal-title":"J Clin Med"},{"key":"2025100312052019000_8.1.e000742.66","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.18632\/oncotarget.23276","article-title":"Protein dysregulation in graft versus host disease","volume":"9","author":"Qian","year":"2018","journal-title":"Oncotarget"},{"key":"2025100312052019000_8.1.e000742.67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00239","article-title":"Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia","volume":"9","author":"Tomuleasa","year":"2018","journal-title":"Front Immunol"},{"key":"2025100312052019000_8.1.e000742.68","doi-asserted-by":"crossref","first-page":"330","DOI":"10.11152\/mu-976","article-title":"Transthoracic ultrasonography for the follow-up of a chronic lymphocytic leukemia patient with chemotherapy-induced immunosuppression prior to allogeneic stem cell transplantation. A case report","volume":"19","author":"Frinc","year":"2017","journal-title":"Med Ultrason"},{"key":"2025100312052019000_8.1.e000742.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-000742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:05:32Z","timestamp":1759518332000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,30]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/jitc-2020-000742"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-000742","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}